MINNEAPOLIS, April 29,
2024 /PRNewswire/ -- Bio-Techne Corporation
(NASDAQ: TECH), a global life sciences company providing innovative
tools and bioactive reagents for the research and clinical
diagnostic communities is pleased to announce a significant
milestone in its commitment to providing cutting-edge solutions to
its customers. Effective May 1, 2024,
Bio-Techne will enter into a strategic distribution agreement with
Thermo Fisher Scientific, a leading provider of laboratory products
and services, in Europe.
This partnership marks an important collaboration between two
industry leaders in the fields of scientific research, diagnostics,
and biotechnology. Under this agreement, Thermo Fisher, through the
European arm of its Fisher Scientific Channel, will distribute
Bio-Techne's extensive portfolio of innovative products, including
antibodies, proteins, Immunoassay kits, reagents and
enzymes to laboratories and research institutions across
Europe.
"We are excited to partner with Thermo Fisher to expand the
reach of our products and services throughout Europe," said Kim
Kelderman, Bio-Techne's President and Chief Executive
Officer. "By leveraging the Fisher Scientific Channel's extensive
European distribution network and industry expertise, we aim to
enhance support for researchers and accelerate scientific
discoveries that address some of the most pressing challenges in
healthcare today."
Bio-Techne's state-of-the-art products are designed to
accelerate research and improve outcomes in areas including cell
and gene therapy, immunology, neuroscience, and more. With this
collaboration, Thermo Fisher reinforces its commitment to providing
customers with access to the latest technologies and expertise,
ultimately advancing scientific knowledge and improving human
health.
"We are thrilled to forge this partnership with Bio-Techne, a
company renowned for its pioneering advancements in the life
sciences industry," said Claire
Wallace, President Research and Safety Market, Europe at Thermo Fisher. "By adding
Bio-Techne's high-quality products to our comprehensive portfolio,
we aim to further empower scientists and researchers with the tools
they need to drive breakthrough discoveries and advancements in
healthcare."
"Thermo Fisher is an ideal partner to accelerate our already
strong presence in Europe," said
Dr. Peter Schüßler, Vice President and General Manager EMEA. "We
are looking forward to the positive impact this relationship will
have on the research community, as expanded access to our portfolio
of bioactive reagents enables scientific discoveries in the
region."
This distribution agreement underscores Thermo Fisher's
dedication to fostering innovation and collaboration within the
scientific community. Through strategic partnerships with leading
companies like Bio-Techne, Thermo Fisher continues to strengthen
its position as a trusted partner for researchers and laboratories
across Europe.
For more information about Bio-Techne and its range of products
and services, visit our Website.
For more information about the Fisher Scientific Channel in
Europe and its comprehensive range
of laboratory products and services, visit their Website.
About Bio-Techne:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences
company providing innovative tools and bioactive reagents for the
research and clinical diagnostic communities. Bio-Techne products
assist scientific investigations into biological processes and the
nature and progress of specific diseases. They aid in drug
discovery efforts and provide the means for accurate clinical tests
and diagnoses. With thousands of products in its portfolio,
Bio-Techne generated over $1.1
billion in net sales in fiscal 2023 and has approximately
3,100 employees worldwide. For more information on Bio-Techne and
its brands, please visit https://www.bio-techne.com or
follow the Company on social media
at: Facebook, LinkedIn, Twitter or YouTube.
Contact:
David Clair, Vice President, Investor Relations &
Corporate Development
david.clair@bio-techne.com
612-656-4416
Fisher Scientific Europe is a part of Thermo Fisher
Scientific.
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue of more than $40 billion. Our Mission is to enable our
customers to make the world healthier, cleaner and safer. Whether
our customers are accelerating life sciences research, solving
complex analytical challenges, increasing productivity in their
laboratories, improving patient health through diagnostics or the
development and manufacture of life-changing therapies, we are here
to support them. Our global team delivers an unrivaled combination
of innovative technologies, purchasing convenience and
pharmaceutical services through our industry-leading brands,
including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher
Scientific, Unity Lab Services, Patheon and PPD.
Contact
Lynn Bannatyne, Director,
EMEA Communications
emeacommunications@thermofisher.com
+44 7534696216
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-distribution-agreement-with-thermo-fisher-scientific-302128389.html
SOURCE Bio-Techne Corporation